Ashwagandha Tea

Ashwagandha tea delivers bioactive withanolides that modulate the HPA axis, activate GABA-A receptors, and upregulate BDNF to reduce cortisol, ease anxiety, and enhance cognitive function. A 2024 scoping review of randomized controlled trials confirmed ashwagandha's role in supporting mental energy and reducing fatigue (PMID 37561965), while a 2025 study highlighted its neuroprotective and cognitive-enhancing potential through antioxidant and anti-inflammatory pathways (PMID 40865615).

Origin & History

Withania somnifera, commonly known as Ashwagandha, is a revered adaptogenic herb native to the arid regions of India, North Africa, and the Middle East. It has been utilized for over 3,000 years in Ayurvedic medicine. As a tea, it offers a gentle yet effective way to access its stress-balancing and vitality-enhancing properties.

Historical & Cultural Context

Ashwagandha has been a cornerstone of Ayurvedic medicine for over 3,000 years, revered as a rasayana (rejuvenative tonic) to promote strength, longevity, and spiritual resilience. It was traditionally consumed by warriors for stamina and by spiritual seekers for grounding and balance, embodying the concept of prana (vital life force).

Health Benefits

- **Regulates cortisol levels,**: reducing the physiological impact of stress and promoting emotional stability.
- **Enhances energy, stamina,**: and physical performance by optimizing mitochondrial function and reducing fatigue.
- **Improves memory, concentration,**: and mental clarity by protecting brain cells from oxidative stress.
- **Modulates immune activity**: by reducing chronic inflammation and enhancing the function of immune cells.
- **Supports hormonal balance,**: including increased testosterone and reproductive health in both men and women.

How It Works

The primary bioactive withanolides in ashwagandha tea—including withaferin A, withanolide D, withanoside IV, and withanoside VI—inhibit cortisol biosynthesis by modulating 11β-hydroxysteroid dehydrogenase (11β-HSD1) activity and attenuating HPA-axis hyperactivation. These compounds bind to GABA-A receptors as positive allosteric modulators, producing anxiolytic and calming effects without significant sedation, while simultaneously upregulating brain-derived neurotrophic factor (BDNF) and PGC-1α to promote neuroplasticity and mitochondrial biogenesis (PMID 29464125; PMID 40865615). At the molecular level, withanolides suppress NF-κB nuclear translocation and inhibit cyclooxygenase-2 (COX-2) expression, reducing systemic pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 (PMID 40154100). This multi-target mechanism—spanning neuroendocrine regulation, GABAergic neurotransmission, and inflammatory signaling—explains ashwagandha tea's broad adaptogenic profile.

Scientific Research

A 2024 scoping review published in the Journal of the American Nutrition Association evaluated randomized controlled trials on dietary ingredients for mental energy and identified ashwagandha as a key adaptogen supporting sustained cognitive vitality and fatigue reduction (Nieman KM et al., PMID 37561965). Ahmed et al. (2025) in Neurotoxicology and Teratology provided molecular evidence that ashwagandha exerts neuroprotective and cognitive-enhancing effects through modulation of oxidative stress markers, neuroinflammation, and synaptic plasticity pathways (PMID 40865615). Sangiovanni et al. (2017) in Neural Plasticity demonstrated that botanicals including ashwagandha modulate neuroplasticity via BDNF upregulation, supporting memory consolidation and neuronal survival (PMID 29464125). Additionally, Upadhyay et al. (2025) in the Journal of Ayurveda and Integrative Medicine elucidated ashwagandha's anti-inflammatory activity through NF-κB pathway inhibition and downregulation of pro-inflammatory cytokines TNF-α and IL-6 (PMID 40154100).

Clinical Summary

A randomized controlled trial of 64 adults showed ashwagandha root extract (300mg twice daily) reduced cortisol levels by 27.9% compared to placebo over 60 days. Multiple studies demonstrate 12-15% improvements in VO2 max and significant reductions in stress scale scores. However, most research uses concentrated extracts rather than traditional tea preparations, which contain lower withanolide concentrations. Long-term safety data beyond 3 months remains limited.

Nutritional Profile

- Phytochemicals/Bioactives: Withanolides (adaptogenic, anti-inflammatory, antioxidant), Alkaloids (immune modulation), Saponins (cognitive & cardiovascular support)
- Minerals: Iron, Calcium, Magnesium (trace amounts, supporting oxygen transport, bone health, and muscle function)
- Amino Acids: (support neurotransmitter balance and stress adaptation)

Preparation & Dosage

- Common forms: Dried root for tea, powdered root for infusions, standardized extracts in capsules.
- Tea Preparation: Simmer 1-2 teaspoons of dried root in hot water or milk for 10-15 minutes.
- Dosage: 1-2 cups of tea daily; 300-600 mg of a standardized root extract (1.5%-5% withanolides) once or twice daily.
- Timing: Can be consumed morning or evening, depending on desired effect (energy vs. relaxation).

Synergy & Pairings

Role: Adaptogenic base
Intention: Mood & Stress | Sleep & Recovery
Primary Pairings: - Rhodiola (Rhodiola rosea)
- L-Theanine (Camellia sinensis)
- Lion's Mane (Hericium erinaceus)
- Bacopa (Bacopa monnieri)

Safety & Interactions

Ashwagandha has been associated with cases of herb-induced liver injury (HILI); a 2024 JAMA Network Open study estimated that millions of US adults are potentially exposed to hepatotoxic botanicals including ashwagandha, underscoring the importance of monitoring liver function during prolonged use (PMID 39102266). Halegoua-DeMarzio et al. (2025) in Liver International further highlighted challenges in identifying and preventing herbal-induced liver injury, recommending caution in individuals with pre-existing hepatic conditions (PMID 39136211). Yeung et al. (2018) in Oncology documented that ashwagandha may interact with CYP3A4 and CYP2D6 substrates and can potentiate the effects of immunosuppressants, sedatives, thyroid hormones, and anticoagulants—necessitating clinical review before concurrent use in cancer care (PMID 30334243). A 2025 systematic scoping review in Lupus Science & Medicine identified ashwagandha as an immunostimulatory supplement that may exacerbate autoimmune skin diseases, advising patients with lupus, psoriasis, or other autoimmune conditions to avoid use without physician guidance (PMID 41475897).